The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVLS.L Regulatory News (VLS)

  • There is currently no data for VLS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disclosure re Directors' Participation in Placing

21 Jul 2020 07:00

RNS Number : 5465T
Velocys PLC
21 July 2020
 

News release

Velocys plc

("Velocys" or the "Company")

21 July 2020

Disclosure re directors' participation in the placing and open offer

 

Velocys plc (VLS.L), the sustainable fuels technology company (the "Company"), announces that, further to the announcement on 25 June 2020 advising the proposed subscription by the directors of the Company of an aggregate of 1,200,000 new ordinary shares of 1p each in the Company ("Ordinary Shares") at a price of 5p per new Ordinary Share as part of the placing, and following the subscription by certain directors of the Company for an aggregate of 96,487 new Ordinary Shares at a price of 5p per new Ordinary Share as part of the open offer announced by the Company on 24 June 2020 and 25 June 2020, the corresponding disclosure forms summarised below have today been submitted online to the FCA in relation to these transactions.

 

The resultant interests of the relevant directors and persons closely associated with them in the shares of the Company are:

 

Director

Number of Ordinary Shares held

Percentage of entire issued share capital

1. Philip Holland

1,203,118

0.11%

2. Henrik Wareborn

2,118,445

0.20%

3. Andrew Morris

847,817

0.08%

4. Sandra Shaw

551,091

0.05%

5. Darran Messem

433,333

0.04%

 

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

1. Philip Holland

2. Henrik Wareborn

3. Andrew Morris

4. Cecil Shaw

5. Darran Messem

2.

Reason for the notification

a)

Position / status

1. Non-executive Chairman

2. Chief Executive Officer

3. Chief Financial Officer

4. Person closely associated with a PDMR - Sandra Shaw, Non-executive Director

5. Non-executive Director

b)

Initial notification / amendment

Initial notification

3.

Details of issuer

a)

Name

Velocys plc

b)

LEI

549300KGMQV70HA5Y715

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification Code

Ordinary Shares of 1p each

 

1. GB00B11SZ269

2. GB00B11SZ269

3. GB00B11SZ269

4. GB00B11SZ269

5. GB00B11SZ269

 

b)

Nature of the transaction

Subscription for new Ordinary Shares.

The transaction is not linked to the exercise of a share option programme.

c)

Price(s) and volume(s)

Director/PCA Name

Price

Volume

1. Philip Holland

5p

230,224

2. Henrik Wareborn

5p

451,779

3. Andrew Morris

5p

414,484

4. Cecil Shaw

5p

100,000

5. Darran Messem

5p

100,000

d)

Aggregated information

Aggregated volume Price

 N/A

e)

Date of the transactions

Director/PCA Name

Date of Transaction

1. Philip Holland

2020-07-16 GMT

2. Henrik Wareborn

2020-07-16 GMT

3. Andrew Morris

2020-07-16 GMT

4. Cecil Shaw

2020-07-16 GMT

5. Darran Messem

2020-07-16 GMT

f)

Place of the transaction

Outside a trading venue

 

 

 

- Ends -

For further information, please contact:

Velocys

Henrik Wareborn, CEO

Andrew Morris, CFO

Lak Siriwardene, Head of Communications & Sustainability

 

+44 1865 800821

 

Numis Securities (Nomad and joint broker)

Stuart Skinner

Louis McKeeve

 

+44 20 7260 1000

Canaccord Genuity (Joint broker)

Henry Fitzgerald-O'Connor

James Asensio

+44 20 7523 8000

 

 

 

Turner Pope Investments (Joint broker)

James Pope

 

Radnor Capital (Investor relations)

Joshua Cryer

Iain Daly

+44 20 3657 0050

 

 

+44 20 3897 1830

 

 

Field Consulting (PR)

Robert Jeffery

 

+44 20 7096 7730

 

 

www.velocys.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHURABRRSUBUAR
Date   Source Headline
10th Nov 20217:01 amRNSSAF OFFTAKE WITH IAG
10th Nov 20217:00 amRNSSAF OFFTAKE WITH SOUTHWEST AIRLINES
28th Oct 20214:40 pmRNSSecond Price Monitoring Extn
28th Oct 20214:35 pmRNSPrice Monitoring Extension
20th Oct 20214:35 pmRNSPrice Monitoring Extension
24th Sep 20217:00 amRNSInvestor Presentation
23rd Sep 20217:00 amRNSHalf-year Report
14th Sep 20217:00 amRNSUS government SAF policy support
1st Sep 20217:00 amRNSGrant of up to £2.4M awarded for Altalto project
31st Aug 20217:00 amRNSVelocys collaboration with Toyo advances
25th Aug 20217:00 amRNSE-fuels project
20th Aug 20214:40 pmRNSSecond Price Monitoring Extn
20th Aug 20214:35 pmRNSPrice Monitoring Extension
18th Aug 20214:41 pmRNSSecond Price Monitoring Extn
18th Aug 20214:35 pmRNSPrice Monitoring Extension
11th Aug 20217:00 amRNSHolding(s) in Company
3rd Aug 20219:00 amRNSApplication for Block Admission
26th Jul 20217:00 amRNSDirectorate Change
5th Jul 202111:55 amRNSBlock listing Interim Review
1st Jul 202110:00 amRNSTotal Voting Rights
30th Jun 20217:00 amRNSVelocys U.S. SAF project update
23rd Jun 20212:38 pmRNSResult of AGM
21st Jun 20217:00 amRNSVelocys technology powers first commercial flight
1st Jun 20217:00 amRNSTotal Voting Rights
27th May 20217:00 amRNSMailing of 2020 annual report and AGM notice
20th May 20211:28 pmRNSInvestor Presentation
18th May 202111:58 amRNSDirector/PDMR Shareholding
17th May 20217:00 amRNSFinal Results
12th May 20214:40 pmRNSSecond Price Monitoring Extn
12th May 20214:35 pmRNSPrice Monitoring Extension
12th Apr 20211:51 pmRNSHolding(s) in Company
30th Mar 20218:14 amRNSVelocys and British Airways extend Altalto option
30th Mar 20217:00 amRNSVelocys and British Airways extend Altalto option
17th Mar 20214:36 pmRNSPrice Monitoring Extension
23rd Feb 20214:36 pmRNSPrice Monitoring Extension
10th Feb 20217:00 amRNSDirector/PDMR Shareholding
8th Feb 20217:00 amRNSToyo and Velocys execute a Collaboration Agreement
1st Feb 202112:17 pmRNSTotal Voting Rights
18th Jan 20217:00 amRNSStrategy/Company/Ops Update
5th Jan 202112:00 pmRNSBlock listing Interim Review
16th Dec 20207:00 amRNSChange of Adviser
15th Dec 20207:00 amRNSResolution of Ventech Trustees Claim
27th Nov 20204:41 pmRNSSecond Price Monitoring Extn
27th Nov 20204:37 pmRNSPrice Monitoring Extension
24th Nov 20204:35 pmRNSPrice Monitoring Extension
12th Nov 20204:41 pmRNSSecond Price Monitoring Extn
12th Nov 20204:36 pmRNSPrice Monitoring Extension
2nd Nov 202011:09 amRNSTotal Voting Rights
17th Sep 20207:00 amRNSHalf-year Report
2nd Sep 20201:59 pmRNSResults of Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.